Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

The company emphasized its commitment to data privacy ... Regeneron umbrella, with more information about post-deal operations to be shared once the transaction is finalized. Joe Selsavage ...

In a statement, Regeneron said it would adhere to the existing privacy policy covering some 15 million customers, even as those consumers continue to have privacy concerns over sensitive genetic data.

The company’s co-founder and CEO ... Regeneron emphasized that it sees significant value in preserving and expanding 23andMe’s core mission of empowering individuals through genetic insights.

The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a judge’s permission to consider another bid from its co-founder and ...

Attorneys for co-founder and former CEO Anne Wojcicki plan an objection to 23andMe's sale to Regeneron. © 2025 American City Business Journals. All rights reserved ...